(Q45249072)

reason for preferred rank

11 December 2017

Synergistic activities of type I (α, β) and type II (γ) murine interferons (English)

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

19 September 2023

Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

19 September 2023

author name string

A. Zerial

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

A. G. Hovanessian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

S. Stefanos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

K. Huygen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

G. H. Werner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

E. Falcoff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6293377

19 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6293377

19 September 2023

publication date

1 September 1982

1 reference

full work available at URL

11 December 2017

https://api.elsevier.com/content/article/PII:0166354282900456?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

https://api.elsevier.com/content/article/PII:0166354282900456?httpAccept=text/plain

19 September 2023

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

19 September 2023

1 reference

11 December 2017

2

1 reference

11 December 2017

227-239

1 reference

11 December 2017

4

1 reference

Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon

11 December 2017

2

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Evidence that types I and II interferons have different receptors

19 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells

19 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Interferon enhances the amount of membrane-bound β2-microglobulin and its release from human Burkitt cells

19 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells

19 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon

19 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations

19 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Production of high-titered interferon in cultures of human diploid cells

19 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Intracellular Events in Interferon-Treated Cells

19 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells

19 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Lack of Systematic Correlation between the Interferon Mediated Antiviral State and the Levels of 2-5A Synthetase and Protein Kinase in Three Different Types of Murine Cells

19 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells

19 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors

19 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

19 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

An improved method for titration of mouse hepatitis virus type 3 in a mouse cell culture

19 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Interleukin 2: a class of T cell growth factors

19 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Physico-chemical Characterization and Partial Purification of Mouse Immune Interferon

19 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

Antigenicity of mouse interferons: Distinct antigenicity of the two L cell interferon species

19 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0166-3542(82)90045-6

19 September 2023

Identifiers

1 reference

11 December 2017

1 reference